Aller au contenu principal
Profil bibliographique

Liuting Zhong

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

5Publications signalées
98Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Pneumocystis jirovecii pneumonia detection and treatmentHIV Research and TreatmentAnalytical chemistry methods developmentDrug Solubulity and Delivery SystemsDialysis and Renal Disease Management

Les publications récentes

Accès ouvert 2026 article OpenAlex

Selective glomerular hypofiltration syndrome: a novel renal phenotype associated with cardiovascular disease and adverse outcomes in diabetic kidney disease

Yuan Fang, Xiaodan Guo, Liuting Zhong, Xinyan He et autres

INTRODUCTION: Selective glomerular hypofiltration syndrome (SGHS), defined by a low ratio of estimated glomerular filtration rate using cystatin C (eGFRcys) to estimated glomerular filtration rate using creatinine (eGFRcr), has emerged as a novel kidney dysfunction phenotype. Its role in diabetic kidney disease …

cn (code pays fourni par la source)

0 citations BMJ Open Diabetes Research & Care
2022 article OpenAlex

Molecularly Imprinted Polymers with Enzymatic Properties Reduce Cytokine Release Syndrome

Liuting Zhong, Junqiu Zhai, Yan Ma, Yihong Huang et autres

A core-shell molecularly imprinted polymer nanoparticle with biological enzyme functional characteristics was developed by oxidative polymerization of template protein and polydopamine on the surface of protease-copper phosphate hybrid nanoflowers by molecular imprinting technology and enzyme immobilization technology. The obtained molecularly imprinted polymer …

cn (code pays fourni par la source)

55 citations ACS Nano
Accès ouvert 2020 article OpenAlex

Exenatide-loaded inside-porous poly(lactic-co-glycolic acid) microspheres as a long-acting drug delivery system with improved release characteristics

Junqiu Zhai, Zhanlun Ou, Liuting Zhong, Yue Wang et autres

The glucagon-like peptide-1 receptor agonist exenatide (EXT) is an effective treatment for type 2 diabetes. However, this peptide has a short biological half-life and the delayed release characteristic of current formulations limit its clinical application. Herein, we prepared EXT-loaded inside-porous poly(d,l-lactic-co-glycolic acid …

cn (code pays fourni par la source)

21 citations Drug Delivery

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.